$3.99 -0.05 (%) Arena Pharmaceuticals Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  2. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  3. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  4. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 3, 2014 | 08:09AM EST
  5. Arena Pharma Reports Q3 EPS Loss $0.05, Revenues Of $8.16M Vs. Est. Of $11.0M

    Benzinga | Nov. 3, 2014 | 06:48AM EST
  6. Earnings Scheduled For November 3, 2014

    Benzinga | Nov. 3, 2014 | 05:18AM EST
  7. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  8. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 29, 2014 | 08:12AM EST
  9. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  10. Eisai And Arena Pharmaceuticals Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ (lorcaserin HCl) CIV In Postgraduate Medicine

    Benzinga | Oct. 10, 2014 | 11:37AM EST
  11. Earnings Scheduled For August 1, 2014

    Benzinga | Aug. 1, 2014 | 05:23AM EST
  12. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 11, 2014 | 08:19AM EST
  13. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga | Jul. 7, 2014 | 16:37PM EST
  14. Arena Pharmaceutical Shares Dive On News CEO Sold 40% Of His Shares

    Benzinga | Jul. 7, 2014 | 12:45PM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 7, 2014 | 08:13AM EST
  16. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  17. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  18. Is Arena Pharmaceuticals A Biotech Stock To Watch?

    Benzinga | Jun. 11, 2014 | 14:15PM EST
  19. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  20. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  21. Arena Pharma Posts Q1 Loss Of $0.12/Share, Misses By ~$0.02/Share

    Benzinga | May. 12, 2014 | 18:44PM EST
  22. Earnings Scheduled For May 12, 2014

    Benzinga | May. 12, 2014 | 06:18AM EST
  23. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 28, 2014 | 08:15AM EST
  25. Earnings Scheduled For February 27, 2014

    Benzinga | Feb. 27, 2014 | 04:29AM EST
  26. Bad Earnings Weigh In On Diet Stocks

    Benzinga | Feb. 14, 2014 | 12:22PM EST
  27. Top Trending Tickers On StockTwits For February 14

    Benzinga | Feb. 14, 2014 | 11:06AM EST
  28. #PreMarket Primer: Friday, February 14: A Turnaround

    Benzinga | Feb. 14, 2014 | 07:26AM EST
  29. Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil

    Benzinga | Feb. 12, 2014 | 08:03AM EST
  30. Celgene To Release Earnings At J.P. Morgan Event Mon.

    IBD | Jan. 12, 2014 | 22:35PM EST
  31. The Top Five Drug Launches Of 2013

    IBD | Dec. 31, 2013 | 13:42PM EST
  32. (ARNA) Initiated with a Buy, (ICLD, FONR) Strong Performance on Financial Results

    GuruFocus | Nov. 16, 2013 | 14:11PM EST
  33. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 15, 2013 | 08:16AM EST
  34. Market Wrap For November 11: Relative Quiet as Traders and Investors Observe Holiday

    Benzinga | Nov. 11, 2013 | 17:44PM EST
  35. Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies Dominate Headlines

    Benzinga | Nov. 8, 2013 | 16:57PM EST
  36. Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ

    Benzinga | Nov. 7, 2013 | 16:03PM EST
  37. Nasdaq Leads Stocks Lower; Twitter IPO Opens To 80% Gain

    IBD | Nov. 7, 2013 | 11:59AM EST
  38. How Arena’s “$3 Billion” Belviq Withered

    YCharts | Nov. 1, 2013 | 12:38PM EST
  39. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 1, 2013 | 08:13AM EST
  40. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down

    Benzinga | Oct. 15, 2013 | 16:36PM EST
  41. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga | Oct. 15, 2013 | 15:30PM EST
  42. Mid-Morning Market Update: Markets Slip; Citigroup Profit Misses Estimates

    Benzinga | Oct. 15, 2013 | 10:39AM EST
  43. UPDATE: Arena Says Eisai Will Double BELVIQ Sales Force to 400 Reps

    Benzinga | Oct. 15, 2013 | 09:04AM EST
  44. Vivus Weighs In As a Leader for Diet Pills, Cowen Upgrades and Raises PT

    Benzinga | Oct. 3, 2013 | 16:42PM EST
  45. Obesity Drug Stocks Jump As Cowen Gets Bullish

    IBD | Oct. 3, 2013 | 13:20PM EST
  46. Benzinga's Top Pre-Market Losers

    Benzinga | Oct. 1, 2013 | 08:43AM EST
  47. Market Wrap For September 30: Debt Ceiling And Government Shutdown Loom

    Benzinga | Sep. 30, 2013 | 16:18PM EST
  48. Mid-Afternoon Market Update: Mellanox Rallies As Market Remains in the Red

    Benzinga | Sep. 30, 2013 | 15:37PM EST
  49. Mid-Day Market Update: Dow Falls Over 100 Points; Active Network Shares Jump

    Benzinga | Sep. 30, 2013 | 13:12PM EST
  50. Mid-Morning Market Update: Markets Open Lower; Cal-Maine Q1 Net Profit Declines 7%

    Benzinga | Sep. 30, 2013 | 10:31AM EST
Trading Center